The Danger of Applying the ProtecT Trial to Minority Populations.
作者信息
McClelland Shearwood, Mitin Timur
机构信息
Department of Radiation Medicine, Oregon Health and Science University, Portland.
出版信息
JAMA Oncol. 2018 Mar 1;4(3):291. doi: 10.1001/jamaoncol.2017.5452.
PMID:29450467
Abstract
摘要
相似文献
1
The Danger of Applying the ProtecT Trial to Minority Populations.
JAMA Oncol. 2018 Mar 1;4(3):291. doi: 10.1001/jamaoncol.2017.5452.
2
Some black men may have more aggressive prostate cancer than scoring indicates.
Cancer. 2019 May 1;125(9):1398-1399. doi: 10.1002/cncr.32133.
3
Komen/ASCO program aims to swell ranks of minority oncologists.
J Natl Cancer Inst. 2009 Feb 18;101(4):224-5, 227. doi: 10.1093/jnci/djp015. Epub 2009 Feb 10.
4
The challenge of minority recruitment in clinical trials for AIDS.
JAMA. 1992 Feb 19;267(7):954-7.
5
New research suggests access, genetic differences play role in high minority cancer death rate.
J Natl Cancer Inst. 2006 May 17;98(10):669. doi: 10.1093/jnci/djj223.
6
Re: Race, prostate cancer survival, and membership in a large health maintenance organization.
J Natl Cancer Inst. 1999 May 5;91(9):801-3. doi: 10.1093/jnci/91.9.801.
7
Screening and prevention trials step up minority recruitment.
J Natl Cancer Inst. 1996 Sep 18;88(18):1265-7. doi: 10.1093/jnci/88.18.1265.
8
Re: Association of African-American ethnic background with survival in men with metastatic prostate cancer.
J Natl Cancer Inst. 2001 Aug 1;93(15):1174-5. doi: 10.1093/jnci/93.15.1174.
9
The science of recruiting minority populations to screening trials.
Clin Trials. 2004;1(4):341-2. doi: 10.1191/1740774504cn034ed.
10
Survival rates of prostate cancer: black vs white patients.
Ethn Dis. 2003 Spring;13(2):298-9.
引用本文的文献
1
Outcomes following radical prostatectomy or external beam radiation for veterans with Gleason 9 and 10 prostate cancer.
Cancer Med. 2022 Aug;11(15):2886-2895. doi: 10.1002/cam4.4656. Epub 2022 Mar 15.
2
Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance.
JAMA. 2020 Nov 3;324(17):1747-1754. doi: 10.1001/jama.2020.17020.
3
The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression.
BJU Int. 2020 Apr;125(4):506-514. doi: 10.1111/bju.14987. Epub 2020 Feb 12.
4
Radiation oncology crossword: Genitourinary cancer.
Rep Pract Oncol Radiother. 2019 May-Jun;24(3):281-283. doi: 10.1016/j.rpor.2019.03.004. Epub 2019 Apr 5.
5
Adjuvant vs. salvage radiation therapy in men with high-risk features after radical prostatectomy: Survey of North American genitourinary expert radiation oncologists.
Can Urol Assoc J. 2019 May;13(5):E132-E134. doi: 10.5489/cuaj.5470. Epub 2018 Oct 15.
6
Application of tumor treating fields for newly diagnosed glioblastoma: understanding of nationwide practice patterns.
J Neurooncol. 2018 Oct;140(1):155-158. doi: 10.1007/s11060-018-2945-y. Epub 2018 Jul 9.
Zotero 插件